Shanghai Shyndec Pharmaceutical (600420.SH) subsidiary obtains the drug registration certificate for Bisoprolol Amlodipine tablets.
GuoYao Modern (600420.SH) announced that its wholly-owned subsidiary, GuoYao Group Rongsheng Pharmaceutical Co., Ltd. (referred to as GuoYao Rongsheng), has received the Drug Registration Certificate for Bisoprolol Amlodipine Tablets issued by the National Medical Products Administration. Bisoprolol Amlodipine Tablets are an alternative therapy for the treatment of hypertension and are suitable for patients who are currently taking a single drug at the same dosage as the compound preparation and have good blood pressure control.
Shanghai Shyndec Pharmaceutical (600420.SH) announced that its wholly-owned subsidiary, China National Pharmaceutical Group Rongsheng Pharmaceutical Co., Ltd. (referred to as Rongsheng), has received the Drug Registration Certificate for Bisoprolol Amlodipine Tablets issued by the National Medical Products Administration. Bisoprolol Amlodipine Tablets, as an alternative therapy for hypertension, are suitable for patients who are currently taking the same dose of a single drug and have good blood pressure control while on compound preparations.
Related Articles
ITC PROPERTIES (00199) is currently experiencing a surge of registrations for its Shenzhen Investor Open Day, focusing on the new developments in the transformation of NEOCLOUD.
HK Stock Market Move | NEXTEER (01316) rises over 4% again, with a year-on-year increase of over 35% in net profit for the first half of the year, and new orders doubling compared to last year.
CA CULTURAL (01566) issues 530.8 million subscription shares and 59 million planned shares.
ITC PROPERTIES (00199) is currently experiencing a surge of registrations for its Shenzhen Investor Open Day, focusing on the new developments in the transformation of NEOCLOUD.
HK Stock Market Move | NEXTEER (01316) rises over 4% again, with a year-on-year increase of over 35% in net profit for the first half of the year, and new orders doubling compared to last year.
CA CULTURAL (01566) issues 530.8 million subscription shares and 59 million planned shares.
RECOMMEND
